Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

09 Aprile 2019

Cervical carcinoma is the fourth most common cancer in women and a major cause of morbidity and mortality worldwide.1 In developed countries where organised cervical screening programmes have been implemented, the incidence and mortality from cervical cancer has decreased, although in many there is either no further diminution or even an increase in incidence. Many factors might contribute to these trends, including decreased uptake of screening, increased rates of human papillomavirus (HPV) infection, and changes in sexual behaviour.23 Middle and lower income countries mostly do not have the resources to support organised screening, and cervical cancer remains a considerable problem. The development of vaccines against the most important oncogenic HPV types has the potential to be a major step in the prevention of cervical cancer…

Prosegui la lettura su “The BMJ

Avviso sui cookie di WordPress da parte di Real Cookie Banner